AstraZeneca: FLUMIST (Influenza, Vaccine Live, Intranasal), the Nation's Only Nasal Spray Flu Vaccine, Now Available for Home Delivery
August 16, 2025
August 16, 2025
WILMINGTON, Delaware, Aug. 16 -- AstraZeneca, a biopharmaceutical company, issued the following news release on Aug. 15, 2025:
* * *
FLUMIST (Influenza, Vaccine Live, Intranasal), the nation's only nasal spray flu vaccine, now available for home delivery
AstraZeneca launches the first FDA-approved influenza vaccine available for self- or caregiver administration, providing a convenient, household-based option for seasonal flu vaccination
* . . .
* * *
FLUMIST (Influenza, Vaccine Live, Intranasal), the nation's only nasal spray flu vaccine, now available for home delivery
AstraZeneca launches the first FDA-approved influenza vaccine available for self- or caregiver administration, providing a convenient, household-based option for seasonal flu vaccination
* . . .